Maternal Lopinavir/Ritonavir Is Associated with Fewer Adverse Events in Infants than Nelfinavir or Atazanavir

Table 1

Infant demographics and select obstetrical characteristics.

Characteristic	Number of infants/number evaluated (%)
Race
Caucasian	92/158 (58%)
African American	53/158 (34%)
American Indian/Alaskan Native	2/158 (1%)
Other/unknown	11/158 (7%)
Ethnicity
Hispanic	55/158 (34%)
Not Hispanic	94/158 (60%)
Other/unknown	10/158 (6%)
Sex, male	81/152 (53%)
Entry maternal CD4 count
<200 cells/mm^3	7/101 (7%)
200–500 cells/mm^3	40/101 (40%)
>500 cells/mm^3	54/101 (53%)
Entry median maternal HIV RNA copies/mL in plasma (range)	2120 (<20–213,191)
Antiretrovirals initiated before conception	44/152 (29%)
Maternal illicit drug use	19/158 (12%)
Mean gestational age in weeks (range)	37.7 (25–41.7)
Preterm deliveries	26/150 (17%)
Deliveries via Cesarean section	64/158 (41%)

Denominator represents the number of infants with available data.
Unless units of measurement are otherwise indicated.
Infant race and ethnicity determined by maternal self-report.
From earliest known maternal laboratory values during pregnancy.